• Thumbnail for Acipimox
    Acipimox (trade name Olbetam in Europe) is a niacin derivative used as a lipid-lowering agent. It reduces triglyceride levels and increases HDL cholesterol...
    5 KB (358 words) - 21:19, 4 December 2022
  • cause hyperglycemia and may also cause liver damage. The niacin derivative acipimox is also associated with a modest decrease in LDL. Bile acid sequestrants...
    11 KB (1,251 words) - 17:11, 6 June 2024
  • Thumbnail for Burn
    Auger C, Knuth CM, Abdullahi A, Jeschke MG. Inhibition of Lipolysis With Acipimox Attenuates Postburn White Adipose Tissue Browning and Hepatic Fat Infiltration...
    82 KB (8,287 words) - 10:04, 2 November 2024
  • Aluminium nicotinate C10AD05 Nicotinyl alcohol (pyridylcarbinol) C10AD06 Acipimox C10AD52 Nicotinic acid, combinations C10AX01 Dextrothyroxine C10AX02 Probucol...
    4 KB (434 words) - 04:44, 18 December 2023
  • Acihexal (Hexal Australia) [Au], also known as aciclovir Acilac Aciphex acipimox (INN) acitazanolast (INN) acitemate (INN) acitretin (INN) acivicin (INN)...
    7 KB (374 words) - 20:35, 27 August 2024
  • metabolism. It is activated by PPAR inhibitors such as rosiglitazone) Acipimox Hydroxycitrate Dipeptidyl peptidase 4 (DPP-4) inhibitors Iodoacetate Mannoheptulose...
    23 KB (2,847 words) - 12:04, 25 March 2024
  • Thumbnail for Leptin
    plasma leptin concentrations have been observed to gradually increase when acipimox is administered to prevent lipolysis, concurrent hypocaloric dieting and...
    113 KB (13,115 words) - 13:48, 9 October 2024
  • Thumbnail for Hydroxycarboxylic acid receptor 2
    (Acifran also binds to HCA3 but with less affinity for it than for HCA3), Acipimox, SCH 900271, MK-6892, MK-1903, GSK256073, and N2L. Lipolysis is the metabolic...
    50 KB (6,317 words) - 17:37, 30 March 2024